Skip to main content

Day: February 9, 2022

Patriot Battery Metals Receives Drill Permits, Secures Contractors, and Finalizes Plans for Mobilization of Drill Rigs to the CV5-6 Pegmatites at the Corvette Property, James Bay, QC

VANCOUVER, British Columbia, Feb. 09, 2022 (GLOBE NEWSWIRE) — Patriot Battery Metals Inc. (the “Company” or “Patriot”) (CSE: PMET) (OTCQB: PMETF) (FSE: R9GA) is pleased to announce it has received its drill permits and has formally engaged a drill contractor for a two (2) drill rig exploration program to commence later this month at the Corvette1 Property (the “Property”) located in the James Bay Region of Quebec. The winter phase of the 2022 drill exploration campaign will focus on further delineation of the CV5-6 spodumene pegmatites where the initial four (4) drill holes to test the prospect returned strong lithium-tantalum mineralization, highlighted by drill hole CF21-002 with 0.94% Li2O and 117 ppm Ta2O5 over 155.1 m, and drill hole CF21-003 with 58.1 m at 1.25% Li2O and 194 ppm Ta2O5 (see news release dated February 3rd,...

Continue reading

Oatly to Report Fourth Quarter and Full Year 2021 Financial Results on March 9, 2022

MALMÖ, Sweden, Feb. 09, 2022 (GLOBE NEWSWIRE) — Oatly Group AB (Nasdaq: OTLY) (“Oatly” or the “Company”), the world’s original and largest oat drink company, will report financial results for the fourth quarter and year ended December 31, 2021, on Wednesday, March 9, 2022, before the U.S. market opens. Oatly will host a conference call and webcast at 8:30 a.m. ET on the same day to discuss the results. The conference call and simultaneous, live webcast can be accessed on Oatly’s Investors website at https://investors.oatly.com under “Events.” The webcast will be archived for 30 days. About Oatly We are the world’s original and largest oat drink company. For over 25 years, we have exclusively focused on developing expertise around oats: a global power crop with inherent properties suited for sustainability and human health. Our...

Continue reading

Selecta Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare Conference

WATERTOWN, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology company leveraging its clinically validated ImmTOR™ platform to develop tolerogenic therapies that selectively mitigate unwanted immune responses, today announced that Company’s Management will provide a corporate update and participate in one-on-one investor meetings at the SVB Leerink 11th Annual Global Healthcare Conference, to be held virtually February 14-18, 2022. SVB Leerink 11th Annual Global Healthcare conferenceFormat: Presentation and one-on-one investor meetingsPresentation Date: Friday February 18th, 2022Presentation Time: 1:00 p.m. ESTWebcast: Click Here An archived webcast will also be accessible in the Investors & Media section of the company’s website at www.selectabio.com. About Selecta Biosciences,...

Continue reading

CRISPR Therapeutics to Participate in the 11th Annual SVB Leerink Global Healthcare Conference

ZUG, Switzerland and CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases, today announced that members of its senior management team are scheduled to participate in the 11th Annual SVB Leerink Global Healthcare Conference on Wednesday, February 16, 2022, at 1:40 p.m. ET. A live webcast of the event will be available on the “Events & Presentations” page in the Investors section of the Company’s website at https://crisprtx.gcs-web.com/events. A replay of the webcast will be archived on the Company’s website for 14 days following the presentation. About CRISPR Therapeutics CRISPR Therapeutics is a leading gene editing company focused on developing transformative gene-based...

Continue reading

Immunovant to Present at the 11th Annual SVB Leerink Global Healthcare Conference

NEW YORK, Feb. 09, 2022 (GLOBE NEWSWIRE) — Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage biopharmaceutical company focused on enabling normal lives for people with autoimmune diseases, today announced that Pete Salzmann, M.D., Chief Executive Officer, will participate in a fireside chat at the 11th Annual SVB Leerink Global Healthcare Conference, taking place February 14 – 18, 2022.11th Annual SVB Leerink Global Healthcare Conference       Date:     Wednesday, February 16th, 2022       Time:     11:20am Eastern Time       Webcast:     The presentation will be available via webcast and can be accessed at the Investor Relations section of the Company’s website, located at www.immunovant.comAbout Immunovant, Inc.  Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal...

Continue reading

Singing Machine to Announce its Financial Results for the Third Quarter Fiscal 2022

Fort Lauderdale, FL, Feb. 09, 2022 (GLOBE NEWSWIRE) — The Singing Machine Company, Inc. (“Singing Machine” or the “Company”) (OTCQX: SMDM) — the North American leader in consumer karaoke products — today announced that its earnings for its third quarter fiscal 2022 will be released on Monday, February 14, 2022. The same day Management will host a conference call at 4:00 pm Eastern time to discuss the financial results and provide a business update. Conference Call Details: Date: Monday, February 14, 2022Time: 4:00 PM ET Dial-in number: (866) 518-6930Conference ID: SMDM An audio rebroadcast of the call will be available later in the day at: http://www.singingmachine.com/investors About The Singing Machine Singing Machine® is the leading provider of karaoke products to consumers across the world. The Company offers the...

Continue reading

BrewBilt Brewing Co. Begins Construction of Craft Brewery Facility

Grass Valley, CA, Feb. 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Today BrewBilt Brewing Company (the “Company”) (OTCPINK: BRBL) announced that it has commenced construction of its new commercial brewery space in Grass Valley, California. CEO Jef Lewis stated, “The Company has assigned the construction project to Bozarth Construction which will begin work immediately. The approximately 7,000-square foot building will allow BrewBilt to launch craft beer sales throughout California and beyond.” Mr. Lewis further stated, “The plans for our Phase I brewery include a 20-bbl brewhouse capable of producing at least 4,000 bbls annually with a revenue potential of $3.5 million.” Follow us on Twitter (@BrewBiltBrewing) and Instagram (@BrewBilt_Brewing) ABOUT BREWBILT BREWING COMPANY: (http://www.brewbiltbrewing.com) Located...

Continue reading

BrewBilt Manufacturing on the Way to European Craft Beer Market

Grass Valley, CA, Feb. 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Today BrewBilt Manufacturing Inc. (the “Company”) (OTCPINK: BBRW) announced that its distribution partner in Finland has officially closed the required bank financing to purchase their BrewBilt Manufacturing brewhouse and fermentation tanks, which will serve as the production hub of their Mad Finn Brewing Company as well as a BrewBilt showroom for sales to European markets by Brewery Ninjas, their brewery equipment distribution arm. CEO Jef Lewis stated, “The Company has been working diligently with South Pacific Traders Oy, the parent company of Brewery Ninjas and Mad Finn Brewing Company in Finland. Brewery Ninjas plans on selling BrewBilt Manufacturing equipment to the European community, while Mad Finn anticipates brewing in their...

Continue reading

Xalles Expands into NFT and Crypto Marketplaces

NFT and crypto trading analysis and asset acquisitions expected to lead to new revenue and profits. WASHINGTON, DC, Feb. 09, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Xalles Holdings Inc. (OTC: XALL), a fintech holding company providing innovative technology and financial services solutions, through its Xalles Capital group of subsidiaries, plans to expand our reach into the market of NFTs (non-fungible tokens) and cryptocurrency trading solutions. Vigor Crypto Holdings, a wholly owned subsidiary of Xalles Capital, will analyze and test a variety of bots that are NFTs which trade on broader exchanges and futures markets like the Nasdaq, S&P 500, NYSE/Dow Jones.  The goal is to evaluate, purchase and enhance our automated trading and bot portfolio, realizing that the key to success is finding the good system tool to...

Continue reading

Amdocs 5G Solutions Expand to Accelerate 5G Standalone Networks Experiences and Monetization Opportunities

5G standalone networks open up a world of new potential and revenue streams, with network orchestration and automation being critical pieces of the puzzle JERSEY CITY, N.J., Feb. 09, 2022 (GLOBE NEWSWIRE) — Amdocs (NASDAQ: DOX), a leading provider of software and services to communications and media companies, announced the expansion of its 5G Value Plane offerings to seamlessly serve emerging 5G standalone networks. By embedding cross-network automation across all aspects of the business, communications service providers (CSPs) can unlock the full potential of 5G. While the promise of new 5G use cases and business models are high, the reality is rushing in as CSPs look for real 5G monetization opportunities to justify their investments. The broader potential of 5G lies in the ability to dynamically leverage the 5G network in different...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.